Impact of Hepatitis B Virus Infection on Human Immunodeficiency Virus Response to Antiretroviral Therapy in Nigeria
Open Access
- 15 October 2009
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 49 (8), 1268-1273
- https://doi.org/10.1086/605675
Abstract
Background. As highly active antiretroviral therapy (ART) is introduced into areas of the world in which hepatitis B virus (HBV) infection is highly endemic, it is important to determine the influence of HBV on persons with human immunodeficiency virus (HIV) and HBV coinfection who are receiving ART. Methods. We studied 1564 HIV-infected patients in Jos, Nigeria, who initiated ART. Participants with HIV-HBV coinfection had hepatitis B e antigen (HBeAg) and HBV DNA status determined. CD4+T cell count and HIV load at ART initiation were compared between individuals with HIV monoinfection and those with HIV-HBV coinfection with use of univariate methods. Regression analyses were used to determine if HBeAg status or HBV DNA at ART initiation were associated with baseline HIV parameters or ART response. Results. The median CD4+T cell count of the 262 participants with HIV-HBV coinfection (16.7%) was 107 cells/mL, compared with 130 cells/mL for participants with HIV monoinfection at ART initiation (P<.001). Participants with HIV-HBV coinfection also had higher HIV loads than did patients with HIV monoinfection (4.96 vs 4.75 log10copies/mL; p=.02). Higher HBV DNA and detectable HBeAg levels were independently associated with lower CD4+T cell counts at ART initiation but not with higher HIV loads. In a multivariable model, HBeAg-positive patients were less likely than HBeAg-negative patients to suppress HIV replication to ⩽400 copies/mL (odds ratio, 0.54; P=.03) at 24 weeks, but they had similar CD4+T cell increases. At 48 weeks, there was no significant effect of HBeAg status on ART response. Conclusions. Among HIV-infected Nigerian individuals, HBV coinfection, especially among those with high levels of HBV replication, was associated with lower CD4+T cell counts at ART initiation, independent of HIV RNA level. Patients with HBeAg-positive status had a slower virological response to ART, compared with HBeAg-negative patients. Further work is needed to understand the effects of HBV on CD4+T cells.This publication has 21 references indexed in Scilit:
- Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapyJournal of Medical Virology, 2009
- Youth, unemployment, and male gender predict mortality in AIDS patients started on HAART in NigeriaAIDS Care, 2008
- Hepatitis B Virus Infection and Response to Antiretroviral Therapy (ART) in a South African ART ProgramClinical Infectious Diseases, 2008
- Impact of viral replication inhibition by entecavir on peripheral T lymphocyte subpopulations in chronic hepatitis B patientsBMC Infectious Diseases, 2008
- Impact of hepatitis B virus co‐infection on response to highly active antiretroviral treatment and outcome in HIV‐infected individuals: a nationwide cohort studyHIV Medicine, 2008
- Hepatitis B virus DNA is more powerful than HBeAg in predicting peripheral T-lymphocyte subpopulations in chronic HBV-infected individuals with normal liver function testsWorld Journal of Gastroenterology, 2008
- Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational DatabaseJournal of Gastroenterology and Hepatology, 2007
- Human immunodeficiency virus and hepatitus B virus co-infection amog patients in Kano NigeriaNigerian Journal of Medicine, 2007
- Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral LoadGastroenterology, 2006
- Apoptosis observed in peripheral T lymphocytes from patients with chronic hepatitis BGastroenterology, 1996